ORIC
ORIC Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +7.7% ·
share flow +23.3% ·
net new positions +7.1%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 72 | 0 | 59.02M | $639.12M | +7 | −7 |
| Q1 2026 | 75 | +3 | 50.35M | $637.44M | +9 | −6 |
| Q4 2025 | 72 | +1 | 55.15M | $451.14M | +1 | — |
| Q3 2025 | 17 | 0 | 34.78M | $417.41M | — | — |
| Q2 2025 | 14 | +1 | 27.12M | $275.30M | +3 | −2 |
| Q1 2025 | 10 | +1 | 12.33M | $68.78M | +2 | −1 |
| Q4 2024 | 9 | -1 | 9.74M | $78.61M | — | −1 |
| Q3 2024 | 9 | 0 | 7.63M | $78.26M | +1 | −1 |
| Q2 2024 | 9 | — | 8.42M | $59.53M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Viking Global Investors ✦ | 6.57M | 0.0% | $66.71M | 0.2% | Held | 5 | SEC ↗ |
| 2 | BlackRock ✦ (passive) | 4.08M | — | $41.39M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 3 | The Vanguard Group ✦ (passive) | 3.12M | — | $31.72M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 4 | Point72 Asset Management ✦ | 2.85M | New | $28.93M | 0.1% | New | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 2.76M | +107.3% | $28.04M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Fidelity (FMR) ✦ | 2.47M | — | $25.07M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | State Street Global Advisors ✦ (passive) | 1.63M | -25.7% | $16.57M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 1.40M | +174.0% | $14.24M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 9 | Geode Capital Management ✦ (passive) | 1.11M | -15.1% | $11.25M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 10 | Adage Capital Partners ✦ | 365.40K | New | $3.71M | 0.0% | New | 1 | SEC ↗ |
| 11 | Millennium Management ✦ | 350.54K | +549.3% | $3.56M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Wellington Management ✦ | 223.30K | +25.3% | $2.27M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 13 | AQR Capital Management ✦ | 171.43K | +246.1% | $1.74M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 14 | Renaissance Technologies ✦ | 10.20K | New | $103,530 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $28.93M | 0.1% |
| Adage Capital Partners | $3.71M | 0.0% |
| Renaissance Technologies | $103,530 | 0.0% |
Exited
| Two Sigma Investments | $429,604 | was 0.0% |
| Marshall Wace | $266,138 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 181 holders, 119.04M shares, $1.43B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 13.40K sh · $181,258
Officer · 100 sh · $1,350
Officer · 500 sh · $6,752
Officer · 77.00K sh · $1.05M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology